Opinion
Video
Role of PARP Inhibitors in Somatic BRCA Mutations and Data Update for PARP Inhibitors
Author(s):
Panelists discuss how recent data inform their approach to PARP inhibitor use in the metastatic setting, exploring the role of PARP inhibition for somatic BRCA mutations and strategies for managing PALB2 and other homologous recombination deficiency mutations.
Video content above is prompted by the following:
- Dr. Degen asks Dr. Shatsky: In the metastatic setting, how do recent data inform your approach to PARP inhibitor use?
- What are your thoughts on PARP inhibition for somatic BRCA mutations?
- How do you approach PALB2 and other homologous recombination deficiency mutations?
Related Videos
Related Content
